Variant report
Variant | esv3413335 |
---|---|
Chromosome Location | chr9:21980202-21982200 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs77574661 | chr9:21980225-21980226 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs542396259 | chr9:21980226-21980227 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs553196272 | chr9:21980237-21980238 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs371931528 | chr9:21980313-21980314 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs193213173 | chr9:21980427-21980428 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs140664092 | chr9:21980435-21980436 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs182584494 | chr9:21980498-21980499 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs368696133 | chr9:21980507-21980508 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs541860114 | chr9:21980543-21980544 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs555510532 | chr9:21980579-21980580 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs575400435 | chr9:21980581-21980582 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs112173569 | chr9:21980601-21980602 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs544866849 | chr9:21980733-21980734 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs3731227 | chr9:21980744-21980745 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs578222902 | chr9:21980748-21980749 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs540587640 | chr9:21980752-21980753 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs560812268 | chr9:21980755-21980756 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs3731226 | chr9:21980792-21980793 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs375266357 | chr9:21980833-21980834 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs529276819 | chr9:21980855-21980856 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs200227222 | chr9:21980863-21980864 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs542575480 | chr9:21980871-21980872 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs184759084 | chr9:21980897-21980898 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs531668807 | chr9:21980899-21980900 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs534789399 | chr9:21980900-21980901 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs550405015 | chr9:21980902-21980903 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs576086402 | chr9:21980906-21980907 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs190272766 | chr9:21980916-21980917 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs13297747 | chr9:21980941-21980942 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs7874405 | chr9:21980944-21980945 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs531944977 | chr9:21980953-21980954 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs36168473 | chr9:21980970-21980971 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs373665640 | chr9:21980989-21980990 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs375048311 | chr9:21980991-21980992 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs562214260 | chr9:21980992-21980993 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs368965186 | chr9:21981006-21981007 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs71216121 | chr9:21981009-21981010 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs150277060 | chr9:21981018-21981019 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs368242892 | chr9:21981019-21981020 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs372482884 | chr9:21981020-21981021 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs376095781 | chr9:21981023-21981024 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs13302595 | chr9:21981034-21981035 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs199692945 | chr9:21981038-21981039 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs13301751 | chr9:21981039-21981040 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs377553393 | chr9:21981040-21981041 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs200671436 | chr9:21981041-21981042 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs58876895 | chr9:21981052-21981053 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs375235494 | chr9:21981055-21981056 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs546601726 | chr9:21981056-21981057 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs368631762 | chr9:21981057-21981058 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Developmental delay | 21147756 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 22183965 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Cancer | 22183965 | CNVD |
Glioblastoma multiforme | 21569311 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Glioblastoma multiforme | 22291905 | CNVD |
Lung cancer | 21911935 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
head and neck squamous cell carcinoma | 21798897 | CNVD |
Cancer | 21253487 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Glioma | 17123091 | CNVD |
Mental retardation | 17124404 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Leukemia | 19602459 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Leukemia | 18688285 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Coronary Disease | 20032323 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21732550 | CNVD |
Gastric cancer | 22539939 | CNVD |
Cancer | 21183584 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cervical cancer | 21062161 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Glioblastoma | 17090523 | CNVD |
Lung cancer | 16773561 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Bladder cancer | 19088036 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Melanoma | 16977458 | CNVD |
Glioblastoma multiforme | 17369134 | CNVD |
Chagasic megaesophagus | 20163722 | CNVD |
Melanoma | 19566914 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
Glioma | 20126413 | CNVD |
Melanoma | 17363583 | CNVD |
Glioblastoma multiforme | 19115005 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Adenoid cystic carcinoma | 18332873 | CNVD |
Cancer | 20581869 | CNVD |
Glioblastoma multiforme | 21525872 | CNVD |
Oral cancer | 22144094 | CNVD |
Lung cancer | 21569311 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Cancer | 20164920 | CNVD |
Breast cancer | 17142309 | CNVD |
Ependymoma | 18628472 | CNVD |
Ewing''s sarcoma | 18628472 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Breast cancer | 21364760 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Oral cancer | 21386901 | CNVD |
Cancer | 17699850 | CNVD |
Ovarian cancer | 17699850 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Breast cancer | 22522925 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Lung adenocarcinoma | 17982442 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 21272361 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Acute myeloid leukemia | 19651600 | CNVD |
Gastric cancer | 22315472 | CNVD |
Pancreatic cancer | 21811562 | CNVD |
Acute lymphoblastic leukemia | 19129520 | CNVD |
Acute lymphoblastic leukemia | 19039135 | CNVD |
Cancer | 17440616 | CNVD |
Leukemia | 21670474 | CNVD |
Lung cancer | 21512611 | CNVD |
Prostate cancer | 19363497 | CNVD |
Renal cell carcinoma | 21228928 | CNVD |
T-cell acute lymphoblastic leukemia | 16270038 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Cancer | 21278246 | CNVD |
Melanoma | 19011513 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Cancer | 17440070 | CNVD |
Lung cancer | 17440070 | CNVD |
Melanoma | 17440070 | CNVD |
Pancreas cancer | 17440070 | CNVD |
Neuroblastoma | 19638189 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Acute myeloid leukemia | 21518781 | CNVD |
Esophageal cancer | 21518781 | CNVD |
Follicular lymphoma | 21518781 | CNVD |
Glioblastoma multiforme | 21518781 | CNVD |
Mantle cell lymphoma | 21518781 | CNVD |
Neuroblastoma | 21518781 | CNVD |
Ovarian cancer | 21518781 | CNVD |
pediatric acute lymphoblastic leukemia | 21518781 | CNVD |
Colorectal cancer | 21518781 | CNVD |
CNS lymphoma | 21518781 | CNVD |
Autism | 20858261 | CNVD |
Epilepsy | 20858261 | CNVD |
Mental retardation | 20858261 | CNVD |
Lung adenocarcinoma | 22272264 | CNVD |
Neuroblastoma | 22034077 | CNVD |
Glioblastoma multiforme | 21713760 | CNVD |
Bladder cancer | 21909424 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:21977400-21984200 | Enhancers | Dnd41 | blood |
2 | chr9:21979400-21982800 | Weak transcription | Hela-S3 | cervix |
3 | chr9:21980200-21981200 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
4 | chr9:21981200-21982000 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
5 | chr9:21981600-21982200 | Bivalent Enhancer | Monocytes-CD14+_RO01746 | blood |
6 | chr9:21981800-21982000 | Bivalent Enhancer | Primary monocytes fromperipheralblood | blood |
7 | chr9:21981800-21982000 | Bivalent/Poised TSS | Right Atrium | heart |
8 | chr9:21982000-21984200 | Enhancers | Primary monocytes fromperipheralblood | blood |
9 | chr9:21982000-21986400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
10 | chr9:21982200-21982800 | Enhancers | Monocytes-CD14+_RO01746 | blood |